Wave Life Sciences Ltd. (WVE:NASDAQ) closed at $3.13 on November 13, 2026, down 0.79% on the day. The stock trades 85.6% below its 52-week high of $21.73 and 4.3% above its 52-week low of $3.00. Over the past year, it lost 55.8%. Wave Life Sciences Ltd. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 13, 2025, WVE closed higher on 118 days (47%). Its best day was December 8, 2025 (+147.26%) and its worst was March 26, 2026 (-49.59%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 4 times.
Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.
Find more stocks like WVE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.